CD8A and neoplasm: Our study shows that host inhibition of PI3K p110γ can potentially address this limitation, as tumor-bearing Pik3cg−/− mice demonstrated an increase in CD8+ T-cell infiltration into the tumor microenvironment of this poorly immunogenic HNSCC.